FAVO Capital Appoints Healthcare Executive Dr. Wael Barsoum to Board of Directors

FAVO Capital (OTC: FAVO), a diversified financial company with operations in financial services and real estate, has announced the appointment of Dr. Wael Barsoum to its board of directors as an independent director. Barsoum brings extensive leadership experience from his roles as former president and CEO of Cleveland Clinic Florida and current president and chief transformation officer at Healthcare Outcomes Performance Company. His background spans decades in healthcare innovation, governance, and organizational growth, making him a valuable addition to FAVO's leadership team.

Shaun Quin, president of FAVO Capital, emphasized the strategic importance of this appointment, stating that Barsoum's addition reflects the company's commitment to building a board with the independence, depth, and experience necessary to guide FAVO's next chapter. This move comes as FAVO continues to expand its operations across financial services and selective real assets. The company provides alternative, revenue-based funding solutions to small and mid-sized businesses throughout the United States, having supported more than 10,000 businesses through the purchase of future receipts since its inception.

The appointment of an independent director with Barsoum's healthcare background suggests FAVO may be positioning itself for potential expansion or strategic partnerships within the healthcare financing sector. Barsoum's experience in healthcare innovation and organizational transformation could provide valuable insights as FAVO continues to diversify its portfolio and strengthen its balance sheet through selective real assets. The company maintains operations in Florida, New York, and the Dominican Republic, with headquarters in Fort Lauderdale, Florida.

FAVO Capital's commitment to financial transparency, sustainable growth, and long-term value creation for shareholders aligns with the governance expertise Barsoum brings to the board. Investors can access the latest news and updates relating to FAVO in the company's newsroom at https://nnw.fm/FAVO. The full press release detailing Barsoum's appointment is available at https://nnw.fm/gLEvl. This strategic board appointment represents FAVO's ongoing efforts to enhance corporate governance and position the company for future growth opportunities across its diversified business segments.